Cite
MLA Citation
P. Quartier et al.. “AB1186 IL-1beta inhibition with canakinumab in patients with systemic juvenile idiopathic arthritis: Efficacy and safety outcomes from a single-dose, placebo-controlled study.” Annals of the rheumatic diseases, vol. 71, n.d., p. 705. http://access.bl.uk/ark:/81055/vdc_100137792785.0x000063